a developer of ovel, non-invasive, liquid biopsy diagnostics for the early detection of cancer
Industry MedicalSpecialties
A.I.dvisor tells us that OCX and FONR have been poorly correlated (+31% of the time) for the last year. This A.I.-generated data suggests there is low statistical probability that OCX and FONR's prices will move in lockstep.
| Ticker / NAME | Correlation To OCX | 1D Price Change % | ||
|---|---|---|---|---|
| OCX | 100% | -0.95% | ||
| FONR - OCX | 31% Poorly correlated | -0.39% | ||
| MLSS - OCX | 23% Poorly correlated | N/A | ||
| ELUT - OCX | 22% Poorly correlated | -0.31% | ||
| INBS - OCX | 21% Poorly correlated | +6.11% | ||
| WRBY - OCX | 20% Poorly correlated | -6.25% | ||
More | ||||